Andrew Retter Volitionrx LTD (VNRX) insider trading activity

Andrew Retter is Chief Medical Officer of VOLITIONRX LTD. Currently has a direct ownership of 142,175 shares of VNRX, which is worth approximately $76,774. The most recent transaction as insider was on Jun 01, 2025, when has been sold 4,598 shares (Common Stock) at a price of $0.5 per share, resulting in proceeds of $2,299. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 142K

3.31% 3M change

31.25% 12M change

Total Value Held $76,774

Andrew Retter Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 01 2025	SELL Payment of exercise price or tax liability	$2,299 $0.5 p/Share	4,598 Reduced 3.13%	142,175 Common Stock
Jun 01 2025	BUY Grant, award, or other acquisition	-	13,069 Added 8.18%	146,773 Common Stock
May 01 2025	SELL Payment of exercise price or tax liability	$1,917 $0.49 p/Share	3,913 Reduced 2.84%	133,704 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	10,142 Added 6.86%	137,617 Common Stock
Dec 01 2024	BUY Grant, award, or other acquisition	-	9,365 Added 6.84%	127,475 Common Stock
Sep 01 2024	BUY Grant, award, or other acquisition	-	9,784 Added 7.65%	118,110 Common Stock
Jun 01 2024	BUY Grant, award, or other acquisition	-	8,326 Added 7.14%	108,326 Common Stock
May 23 2024	BUY Grant, award, or other acquisition	-	100,000 Added 50.0%	100,000 Common Stock

Andrew Retter

Chief Medical Officer

Henderson, NV

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNRX shares.

Notify only if

Value

Insider Trading

Get notified when an Volitionrx LTD insider buys or sells VNRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VOLITIONRX LTD

Track Activities on VNRX

Account